Healthcare - Quarterly Revenue Analysis

Last updated 2024-09-19 04:45:54 (EDT)

Quarterly Revenue Trend Analysis

Overall Quarterly Revenue Growth Trend of Healthcare Sector Companies.

Trend Chart of Adjusted Quarterly Revenue vs. Stock Price Trend Chart for Healthcare Sector ETF (XLV)

FindBillion.com

Seasonally Adjusted Quarterly Revenue Growth Rate


QoQ Growth Rate of Revenue	2.6%
YoY Growth Rate of Revenue	6.9%

Correlation Analysis between Quarterly Revenue and Stock Price

Determine the correlation between the stock price of the Healthcare Sector ETF (XLV) and the seasonally adjusted overall quarterly revenue of Healthcare sector companies. If there is a moderate to high correlation, the overall seasonally adjusted quarterly revenue can be used to estimate whether the stock price is reasonable.

Scatter Plot of Seasonally Adjusted Quarterly Revenue vs. Stock Price for Healthcare Sector

Seasonally Adjusted Quarterly Revenue and stock price of Healthcare Sector show a High Correlation. The higher the correlation, the greater the reference value.

The Coefficient of Determination
between Seasonally Adjusted Quarterly Revenue and Stock Price

High Correlation 0.94

FindBillion.com

Related Stocks

Related Healthcare sector stocks, along with their quarterly revenue growth rates (QoQ and YoY).

Ticker	Name	QoQ Growth Rate of Seasonally Adjusted Quarterly Revenue	YoY Growth Rate of Seasonally Adjusted Quarterly Revenue
MDGL	Madrigal Pharmaceuticals, Inc.	轉虧為盈%	轉虧為盈%
RETA	Reata Pharmaceuticals, Inc.	11273.7%	2885%
ROIV	Roivant Sciences Ltd.	296.2%	155%
NBIX	Neurocrine Biosciences, Inc.	140.4%	30.4%
LEGN	Legend Biotech Corporation	125.1%	154.4%
SNY	Sanofi	91.4%	98.5%
IONS	Ionis Pharmaceuticals, Inc.	88.6%	19.8%
ARGX	argenx SE	74.5%	224.3%
IMGN	ImmunoGen, Inc.	68.1%	637.7%
KRYS	Krystal Biotech, Inc.	62.6%	轉虧為盈%
ALNY	Alnylam Pharmaceuticals, Inc.	43.1%	107%
MRNA	Moderna, Inc.	43.1%	-29.9%
EXEL	Exelixis, Inc.	41.3%	35.6%
TEM	Tempus AI, Inc. Class A Common Stock	33.8%	25.3%
RCM	R1 RCM Inc.	32%	12%
INSM	Insmed Incorporated	29.8%	17%
INSP	Inspire Medical Systems, Inc.	25.5%	29.6%
LLY	Eli Lilly and Company	25.4%	36%
RARE	Ultragenyx Pharmaceutical Inc.	24%	35.7%
BGNE	BeiGene, Ltd.	21%	56.1%
OSH	Oak Street Health, Inc.	19.8%	46.4%
NTRA	Natera, Inc.	18.6%	58.1%
DOCS	Doximity, Inc.	16%	16.8%
INCY	Incyte Corporation	13%	9.3%
RDY	Dr. Reddy's Laboratories Limited	12.5%	13.9%
GSK	GSK plc	11.7%	9.8%
CI	Cigna Corporation	11.6%	24.4%
HQY	HealthEquity, Inc.	11.1%	23.1%
ABBV	AbbVie Inc.	10.9%	4.3%
GKOS	Glaukos Corporation	10.4%	19%
LNTH	Lantheus Holdings, Inc.	10.2%	22.5%
EXAS	Exact Sciences Corporation	10.2%	12.4%
SNN	Smith & Nephew plc	10.1%	8.7%
PEN	Penumbra, Inc.	9.5%	14.5%
CTLT	Catalent, Inc.	9.3%	21.8%
BRKR	Bruker Corporation	9.3%	17.4%
TEVA	Teva Pharmaceutical Industries Limited	8.7%	7.3%
SWAV	ShockWave Medical, Inc.	8.5%	35.8%
BMRN	BioMarin Pharmaceutical Inc.	8%	19.2%
PODD	Insulet Corporation	7.3%	23.2%
NVO	Novo Nordisk A/S	7.2%	25.3%
GMED	Globus Medical, Inc.	6.9%	115.9%
ALC	Alcon Inc.	6.8%	3.7%
COR	Cencora	6.7%	10.9%
AMGN	Amgen Inc.	6.6%	19.3%
OPCH	Option Care Health, Inc.	6.6%	14.8%
TAK	Takeda Pharmaceutical Company Limited	6.5%	14.1%
ENSG	The Ensign Group, Inc.	6.5%	12.5%
JAZZ	Jazz Pharmaceuticals plc	6.2%	6.9%
STVN	Stevanato Group S.p.A.	6.2%	2.2%
ICLR	ICON Public Limited Company	6%	4.9%
ILMN	Illumina, Inc.	6%	-5.4%
MEDP	Medpace Holdings, Inc.	5.6%	14.6%
ZBH	Zimmer Biomet Holdings, Inc.	5.4%	3.9%
BSX	Boston Scientific Corporation	5.4%	14.5%
HLN	Haleon plc	5.2%	0.8%
ZTS	Zoetis Inc.	4.7%	8.3%
ISRG	Intuitive Surgical, Inc.	4.2%	14.5%
BLCO	Bausch + Lomb Corporation	4.2%	17.5%
SOLV	Solventum Corporation	4.1%	1.8%
HOLX	Hologic, Inc.	4%	2.7%
GRFS	Grifols, S.A.	4%	9.3%
ABT	Abbott Laboratories	3.9%	4%
IQV	IQVIA Holdings Inc.	3.8%	2.3%
CVS	CVS Health Corporation	3.8%	3%
QGEN	Qiagen N.V.	3.8%	0.3%
LH	Laboratory Corporation of America Holdings	3.7%	6.2%
SYK	Stryker Corporation	3.7%	8.5%
ALGN	Align Technology, Inc.	3.6%	2.6%
RPRX	Royalty Pharma plc	3.4%	-0.2%
AZN	AstraZeneca PLC	3.4%	13.3%
JNJ	Johnson & Johnson	3.3%	4.3%
BIO	Bio-Rad Laboratories, Inc.	3.1%	-6.3%
MRK	Merck & Co., Inc.	3.1%	7.5%
HCA	HCA Healthcare, Inc.	3.1%	10.3%
ELAN	Elanco Animal Health Incorporated	2.8%	12%
GEHC	GE HealthCare Technologies Inc.	2.8%	0.5%
PHG	Koninklijke Philips N.V.	2.7%	-0.2%
COO	The Cooper Companies, Inc.	2.7%	7.8%
BIIB	Biogen Inc.	2.6%	-4.2%
REGN	Regeneron Pharmaceuticals, Inc.	2.5%	12.3%
UHS	Universal Health Services, Inc.	2.3%	10.1%
ELV	Elevance Health Inc.	2.2%	-0.1%
TMO	Thermo Fisher Scientific Inc.	2.2%	-1.4%
VRTX	Vertex Pharmaceuticals Incorporated	2.2%	5.7%
VEEV	Veeva Systems Inc.	2.2%	14.6%
BMY	Bristol-Myers Squibb Company	2%	8.7%
HUM	Humana Inc.	1.9%	10.4%
CHE	Chemed Corporation	1.9%	7.6%
NVS	Novartis AG	1.9%	-10.2%
BAX	Baxter International Inc.	1.7%	2.8%
WAT	Waters Corporation	1.6%	-4.3%
DGX	Quest Diagnostics Incorporated	1.6%	2.5%
MCK	McKesson Corporation	1.4%	6.4%
GILD	Gilead Sciences, Inc.	1.3%	5.3%
CAH	Cardinal Health, Inc.	1.2%	8.8%
STE	STERIS plc	1.1%	-0.4%
RGEN	Repligen Corporation	1.1%	-3.2%
UNH	UnitedHealth Group Incorporated	0.8%	6.6%
RVTY	Revvity, Inc.	0.8%	-2.5%
XRAY	DENTSPLY SIRONA Inc.	0.8%	-4.3%
TECH	Bio-Techne Corporation	0.5%	1.6%
HSIC	Henry Schein, Inc.	0.4%	1.2%
ABCM	Abcam plc	0.4%	9.7%
HALO	Halozyme Therapeutics, Inc.	0.4%	4.7%
MMSI	Merit Medical Systems, Inc.	0.4%	5.5%
EHC	Encompass Health Corporation	0.2%	9.6%
DVA	DaVita Inc.	0.2%	6.2%
IDXX	IDEXX Laboratories, Inc.	-0.1%	6.4%
PKI	PerkinElmer, Inc.	-0.3%	-42.3%
MOH	Molina Healthcare, Inc.	-0.9%	18.4%
ACHC	Acadia Healthcare Company, Inc.	-1.2%	8.8%
FMS	Fresenius Medical Care AG & Co. KGaA	-1.3%	-1.2%
DXCM	DexCom, Inc.	-1.4%	15.3%
MDT	Medtronic plc	-1.4%	2.8%
ATR	AptarGroup, Inc.	-1.4%	1.6%
A	Agilent Technologies, Inc.	-1.6%	-5.6%
RMD	ResMed Inc.	-1.7%	9%
THC	Tenet Healthcare Corporation	-1.9%	0.4%
WBA	Walgreens Boots Alliance, Inc.	-2.1%	2.6%
MASI	Masimo Corporation	-2.2%	9%
LHCG	LHC Group, Inc.	-2.3%	-4.3%
ABMD	Abiomed, Inc.	-2.5%	7.2%
TFX	Teleflex Incorporated	-2.5%	0.9%
UTHR	United Therapeutics Corporation	-2.6%	19.8%
CNC	Centene Corporation	-2.6%	5.9%
BDX	Becton, Dickinson and Company	-2.9%	2.3%
VTRS	Viatris Inc.	-3%	-3.4%
WST	West Pharmaceutical Services, Inc.	-3.2%	-6.9%
CRL	Charles River Laboratories International, Inc.	-3.4%	-3.2%
MTD	Mettler-Toledo International Inc.	-5.5%	-3.6%
DHR	Danaher Corporation	-6.9%	-19.8%
OGN	Organon & Co.	-7.6%	-0.1%
SGEN	Seagen Inc.	-11%	27.1%
PFE	Pfizer Inc.	-12%	4.3%
EW	Edwards Lifesciences Corporation	-13.4%	-9.4%
RXDX	Prometheus Biosciences, Inc.	-13.5%	-71.8%
BNTX	BioNTech SE	-16.6%	-22.9%
SRPT	Sarepta Therapeutics, Inc.	-17.5%	38.9%
GMAB	Genmab A/S	-18.7%	28.7%
BPMC	Blueprint Medicines Corporation	-22.8%	140%
SGFY	Signify Health, Inc.	-24.4%	11.9%
ITCI	Intra-Cellular Therapies, Inc.	-38.8%	46.5%
ASND	Ascendis Pharma A/S	-57.1%	-23.7%
CYTK	Cytokinetics, Incorporated	-73.1%	-71.3%
CERE	Cerevel Therapeutics Holdings, Inc.	-100%	-
ISEE	IVERIC bio, Inc.	-	-
KRTX	Karuna Therapeutics, Inc.	-	-100%
NUVL	Nuvalent, Inc.	-	-
PCVX	Vaxcyte, Inc.	-	-
RVMD	Revolution Medicines, Inc.	-	-100%
SMMT	Summit Therapeutics Inc.	-	-100%
VKTX	Viking Therapeutics, Inc.	-	-

Disclaimer

1. The information provided is for reference only and does not constitute any guarantee of profits or specific stock and price point recommendations.

2. The information is not complete; for comprehensive data, please refer to the relevant websites.

3. All stock market data analyses are subject to survivorship bias.